STEP: Proglide® Versus Femoseal®: A Trial to Compare the Efficacy of Arterial Closure Devices Following Endovascular Peripheral Arterial Procedures

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 233 participants.

Also called NCT03192033

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 233 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03192033
Main results
  • A Randomized Trial Comparing Polymer Versus Suture-Based Vascular Closure Devices for Arterial Closure Following Lower-Limb Arterial Endovascular Revascularization Cardiovascular and interventional radiology, 2021-12 DOI, PubMed 34386892

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03192033. Randomized; no masking; primary purpose other. Start 2017-12-04 (actual); primary completion 2019-06-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
STEP: Proglide® Versus Femoseal®: A Trial to Compare the Efficacy of Arterial Closure Devices Following Endovascular Peripheral Arterial Procedures
Acronym
STEP
Condition
Peripheral Arterial Disease
Intervention (Other)
Arterial closure to ensure hemostasis at femoral artery puncture points
Intervention (Device)
Proglide® (Abbott)
Intervention (Device)
Femoseal® (Terumo)
Intervention (Other)
Arterial closure to ensure hemostasis at femoral artery puncture points
Lead sponsor
Nantes University Hospital (class: other)

Record details

Record id
cardio:ct-nct03192033
Content hash
50333a2bbf2ce954033a042470b5257d284026b484cc5bc0a70c17115a1d6f69